Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Dally

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Harefuah|February 2, 1992
[Inapparent infection with hepatitis A virus and glomerulonephritis in a child]D Heldenberg, D Dally
Nurse Educator|July 1, 1989
The write content: a guide for revising and grading texts and manuscriptsK Tarpey-Murray, D Dally
Biochemical Pharmacology|January 1, 1987
Specific, high-affinity bradykinin binding by purified porcine kidney post-proline cleaving enzymeC E Odya, R D Dally, K E Georgiadis
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 1, 1993
Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine bindingD E Johnson, S L Heald, R D Dally, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 7, 2015
Utilizing 19F NMR to investigate drug disposition early in drug discoveryHaitao Hu, Naijia Huang, Ping Yi, et al.
Journal of Medicinal Chemistry|October 28, 2005
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in ratsConrad W Hummel, Andrew G Geiser, Henry U Bryant, et al.
Journal of Medicinal Chemistry|October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft ModelKevin R Fales, F George Njoroge, Harold B Brooks, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safetyTimothy I Richardson, Scott A Frank, Minmin Wang, et al.
Scientific Reports|October 20, 2018
Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine modelsHarold B Brooks, Timothy I Meier, Sandaruwan Geeganage, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Harefuah|February 2, 1992
[Inapparent infection with hepatitis A virus and glomerulonephritis in a child]D Heldenberg, D Dally
Nurse Educator|July 1, 1989
The write content: a guide for revising and grading texts and manuscriptsK Tarpey-Murray, D Dally
Biochemical Pharmacology|January 1, 1987
Specific, high-affinity bradykinin binding by purified porcine kidney post-proline cleaving enzymeC E Odya, R D Dally, K E Georgiadis
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 1, 1993
Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine bindingD E Johnson, S L Heald, R D Dally, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 7, 2015
Utilizing 19F NMR to investigate drug disposition early in drug discoveryHaitao Hu, Naijia Huang, Ping Yi, et al.
Journal of Medicinal Chemistry|October 28, 2005
A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in ratsConrad W Hummel, Andrew G Geiser, Henry U Bryant, et al.
Journal of Medicinal Chemistry|October 27, 2017
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft ModelKevin R Fales, F George Njoroge, Harold B Brooks, et al.
Bioorganic & Medicinal Chemistry Letters|May 8, 2007
Structure-activity relationships of SERMs optimized for uterine antagonism and ovarian safetyTimothy I Richardson, Scott A Frank, Minmin Wang, et al.
Scientific Reports|October 20, 2018
Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine modelsHarold B Brooks, Timothy I Meier, Sandaruwan Geeganage, et al.
Pageof 1